{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:31:50Z","timestamp":1789212710841,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.03.076","type":"journal-article","created":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T07:01:09Z","timestamp":1459062069000},"page":"2976-2981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Status of research and development of vaccines for chikungunya"],"prefix":"10.1016","volume":"34","author":[{"given":"Claire","family":"Smalley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse H.","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Chesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.C.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"July (7)","key":"10.1016\/j.vaccine.2016.03.076_bib0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro2368","article-title":"Biology and pathogenesis of chikungunya virus","volume":"8","author":"Schwartz","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2016.03.076_bib0105","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1586\/erv.12.84","article-title":"Chikungunya virus and prospects for a vaccine","volume":"11","author":"Weaver","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2016.03.076_bib0110","doi-asserted-by":"crossref","first-page":"11644","DOI":"10.1128\/JVI.01432-14","article-title":"Reemergence of chikungunya virus","volume":"88","author":"Morrison","year":"2014","journal-title":"J Virol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2016.03.076_bib0115","first-page":"94","article-title":"Chikungunya virus infections","volume":"373","author":"Weaver","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.076_bib0120","series-title":"Pan American Health Organization program \u2013 Chikungunya","year":"2015"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2016.03.076_bib0125","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1371\/journal.pntd.0001197","article-title":"The Chikungunya epidemic on La Reunion Island in 2005\u20132006: a cost-of-illness study","volume":"5","author":"Soumahoro","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.076_bib0130","first-page":"1","article-title":"Estimation of lasting impact of a Chikungunya outbreak in Reunion Island","volume":"2","author":"Yaseen","year":"2012","journal-title":"Epidemiology: Open Access"},{"issue":"7","key":"10.1016\/j.vaccine.2016.03.076_bib0135","doi-asserted-by":"crossref","first-page":"e2331","DOI":"10.1371\/journal.pntd.0002331","article-title":"Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children","volume":"7","author":"Capeding","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.03.076_bib0140","doi-asserted-by":"crossref","first-page":"e30025","DOI":"10.1371\/journal.pone.0030025","article-title":"Chikungunya infection in India: results of a prospective hospital based multi-centric study","volume":"7","author":"Ray","year":"2012","journal-title":"PLoS ONE"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2016.03.076_bib0145","doi-asserted-by":"crossref","first-page":"e0003764","DOI":"10.1371\/journal.pntd.0003764","article-title":"High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines","volume":"9","author":"Yoon","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2016.03.076_bib0150","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jaci.2015.01.039","article-title":"Control of immunopathology during chikungunya virus infection","volume":"135","author":"Petitdemange","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2016.03.076_bib0155","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/infdis\/jis033","article-title":"Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection","volume":"205","author":"Kam","year":"2012","journal-title":"J Infect Dis"},{"issue":"July (33)","key":"10.1016\/j.vaccine.2016.03.076_bib0160","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2013.05.059","article-title":"Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model","volume":"31","author":"Chu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.076_bib0165","series-title":"Gaps and opportunities in Chikungunya research: expert consultation on Chikungunya disease in the Americas [presentation] 11\/03\/2015","article-title":"Prevention of mother-to-child transmission of Chikungunya infection: clinical evaluation of anti-CHIKV hyperimmune IVIg","author":"Hoen","year":"2015"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2016.03.076_bib0170","doi-asserted-by":"crossref","first-page":"e3354","DOI":"10.1371\/journal.pntd.0003354","article-title":"Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection","volume":"8","author":"Poo","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"June (4)","key":"10.1016\/j.vaccine.2016.03.076_bib0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1179\/2047773215Y.0000000017","article-title":"Do we need a vaccine against chikungunya?","volume":"109","author":"Rezza","year":"2015","journal-title":"Pathog Glob Health"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2016.03.076_bib0180","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/vbz.2014.1681","article-title":"Therapeutics and vaccines against chikungunya virus","volume":"15","author":"Ahola","year":"2015","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"December (9959)","key":"10.1016\/j.vaccine.2016.03.076_bib0185","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2016.03.076_bib0190","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T21:55:47Z","timestamp":1536875747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16300731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":19,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16300731"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Status of research and development of vaccines for chikungunya","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}